Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction
- Status
- RECRUITING
- Phase
- N/A
Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
- Status
- COMPLETED
- Phase
- NA
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
- Status
- UNKNOWN
- Phase
- PHASE2
A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- NA
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring
- Status
- COMPLETED
- Phase
- N/A
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC
- Status
- UNKNOWN
- Phase
- PHASE2
SIRT for Potentially Resectable HCC
- Status
- RECRUITING
- Phase
- NA
Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC
- Status
- RECRUITING
- Phase
- PHASE2
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
- Status
- RECRUITING
- Phase
- PHASE2
Multimodal Ultrasound and Hepatocellular Response to Local Treatments
- Status
- UNKNOWN
- Phase
- NA
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
- Status
- RECRUITING
- Phase
- NA
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2